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A B S T R A C T
Background and purpose: The present diagnostic method and features of syncope in Japan are unclear.
Implantable loop recorder (ILR) and head-up tilt tests have recently become available for diagnosing
syncope. The examination method and rates of diagnosing syncope may vary. This study aimed to clarify
the present diagnostic method and features of syncope in a single Japanese medical center.
Methods and results: We retrospectively reviewed the medical records of consecutive patients who were
seen at our hospital from January 1, 2009, to December 31, 2012. A total of 547 patients (328 men,
60.4  21.5 years) with syncope were seen at our hospital. Reﬂex syncope was diagnosed in 29.1% of the
cases, orthostatic hypotension in 11.7%, cardiac syncope in 34.0%, and unexplained syncope in 23.9% by initial
and early evaluations. The number of patients with situational syncope and orthostatic hypotension that
could be diagnosed in the initial evaluation of the ﬁrst examination was signiﬁcantly greater than that in
subsequent evaluations. Forty-three percent of the unexplained syncope patients received an ILR. The
consent rate for ILR implantations in the unexplained syncope patients with a suspected arrhythmia nature
was 53.1%. The cumulative ILR diagnostic rates were 47% and 65% at 1 and 2 years after the ILR implantation,
respectively. The estimated ILR diagnostic rates were signiﬁcantly greater than that for conventional test
without using an ILR. When patients with unexplained syncope could be diagnosed, the recurrent symptoms
were greatly reduced.
Conclusions: Syncope is induced by various causes in Japan. It is important that we understand the
characteristics of each syncope cause. The consent rate for implanting an ILR in appropriate unexplained
syncope patients is low. We need to educate these patients about the importance of making a diagnosis
of syncope.
 2015 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.
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Syncope is deﬁned as a sudden loss of consciousness associated
with a loss of postural tone, from which the patient recovers
spontaneously. In Western countries, syncope is a common
condition accounting for 1–6% of medical admissions and up to
3% of emergency department visits [1]. There are various causes of
syncope and the prognosis of syncope differs according to the
cause [1,2]. Actually, the prognosis is bad in cardiac syncope
patients and good in reﬂex syncope patients [2]. Cardiovascular* Corresponding author at: Division of Cardiology, Department of Medicine,
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syncope. Moreover, in clinical practice, the features of Japanese
syncope are unclear. Implantable loop recorder (ILR) and head-up
tilt test (HUT) have become available for diagnosing syncope in
recent years in Japan. ILR is useful for diagnosing unexplained
syncope [3–6] and HUT is performed to conﬁrm the diagnosis in
suspected reﬂex syncope patients [7]. The examination method
and diagnosis appear to have been improved by those tests. To
conﬁrm the facts and features of the diagnosis is of signiﬁcance for
syncope patients in Japan. The syncope guidelines of the European
Society of Cardiology (ESC) were revised in 2009 [8], and the
Japanese guidelines were made from that. The guidelines state
the new risk classiﬁcation for unexplained syncope patients
[8]. According to the guidelines, we retrospectively analyzed the
diagnostic methods and causes of the disease in Japanese syncope
patients. reserved.
Table 1
High-risk features of unexplained syncope according to the European Society of
Cardiology guidelines [8].
(1) Severe structural or coronary artery disease
1. Heart failure
2. Low LVEF
3. Previous myocardial infarction
(2) Clinical or ECG features suggesting arrhythmic syncope
1. Syncope during exertion or supine
2. Palpitations at the time of syncope
3. Family history of SCD
4. Non-sustained VT
5. Bifascicular-block (LBBB or RBBB combined with anterior or left posterior
fascicular block) or other intraventricular conduction abnormalities with a QRS
duration 120 ms
6. Inadequate sinus bradycardia (<50 bpm) or sinoatrial block in absence of
negative chronotropic medications or physical training
7. Pre-excited QRS complex
8. Prolonged or short QT interval
9. RBBB pattern with ST-elevation in leads V1–V3 (Brugada pattern)
10. Negative T wave in the right precordial leads, epsilon waves, and ventricular
late potentials suggestive of ARVC
(3) Important comorbidities
1. Severe anemia
2. Electrolyte disturbance
LVEF, left ventricular ejection fraction; VT, ventricular tachycardia; SCD, sudden
cardiac death; LBBB, left bundle branch block; RBBB, right bundle branch block;
bpm, beats per minute; ARVC, arrhythmogenic right ventricular cardiomyopa-
thy.
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Patient population
We retrospectively reviewed the medical records of 547 conse-
cutive patients, from the inpatients and outpatients, who
consulted the cardiovascular internal medicine department in
our hospital for syncope from January 1, 2009 to December 31,
2012. The patients were excluded from the study if they were
experiencing typical non-syncopal events, namely other disorders
with impairment or loss of consciousness resembling syncope (i.e.
transient ischemic attacks, metabolic disorders, epilepsy, intoxi-
cation, cataplexy, drop attacks, and psychogenic disorders). In
addition, the patients were excluded if they had head trauma
without a syncopal episode, or had a prolonged loss of conscious-
ness disorder. The study was approved by the Ethics Committee of
Showa University.
Diagnosis criteria
The patients were diagnosed by 2 cardiovascular medicine
specialists using the classiﬁcation and pathophysiology of syncope
described in the ESC guidelines [8]. The diagnoses were sorted into
three categories: Reﬂex syncope, syncope due to orthostatic
hypotension (OH), and cardiac syncope. Reﬂex syncope was
deﬁned as syncope triggered by pain, micturition or defecation,
prolonged standing, stress, or HUT-induced syncope with a
prodrome similar to the clinical symptoms. Syncope due to OH
included not only general initial, classic, and delayed OH, but also
OH together with reﬂex syncope and postural orthostatic
tachycardia syndrome. OH was diagnosed on the basis of an
abnormal decrease in the blood pressure upon standing during the
active standing test or HUT. Cardiac syncope included arrhythmias,
ischemic heart disease, and mechanical causes as represented by
aortic valve stenosis and hypertrophic obstructive cardiomyopa-
thy. Arrhythmic causes of syncope were diagnosed on the basis of
documented arrhythmic events or positive electrophysiological
study (EPS). Ischemic heart disease was diagnosed by the
electrocardiogram (ECG) and coronary angiography including an
acetylcholine stress test (CAG). Organic cardiac causes of syncope
(i.e. aortic valve stenosis, hypertrophic obstructive cardiomyopa-
thy, etc.) were conﬁrmed by echocardiography. Non-syncope was
deﬁned as epilepsy, several metabolic disorders (i.e. hyponatremia
and hypoglycemia), or vertebrobasilar transient ischemic attacks.
Diagnosis of syncope (initial evaluation, early evaluation, and late
evaluation)
We sorted the initial, early, and late evaluations according to
the time of the tests for syncope. We deﬁned the initial evaluation
as examinations on the day that the patient consulted the medical
institution for syncope for the ﬁrst time. An early evaluation was
deﬁned as tests performed within three months after the syncope.
We examined and diagnosed the patients during each evaluation
period. Nevertheless, we could not diagnose the patients who were
diagnosed with unexplained syncope. We followed up the patients
in late evaluation.
Initial evaluation (primary evaluation)
We deﬁned the initial evaluation as possible examinations (i.e.
detailed history and blood examination, ECG at the time of the
consultation, and standing test), and as appropriate, when these
syncope patients were examined for the ﬁrst time.
We diagnosed reﬂex syncope and OH by a clinical history
of syncope or positive active standing test. Cardiac syncope
was conﬁrmed from ECG abnormalities causing the syncope(e.g. complete atrioventricular block and ST elevation due to a
myocardial infarction, etc.) at the time of the consultation.
Early evaluation (secondary evaluation)
If we could not diagnose the patients with syncope in the initial
evaluation, these patients needed a secondary evaluation. An early
evaluation was deﬁned as tests performed during the admission
for syncope or during outpatient visits within three months after
the onset of the syncope. The tests during the early evaluation
period included invasive tests such as an EPS, CAG, and the
available tests during the outpatient care (e.g. ultrasound
cardiography, 24 hours Holter ECG, and HUT).
Reﬂex syncope and OH were induced and diagnosed using HUT.
We diagnosed structural cardiovascular disease using echocardi-
ography, CAG, or contrast-enhanced computed tomography scan.
Arrhythmias were diagnosed by positive EPS or documented
arrhythmias causing syncope by prolonged ECG or treadmill test.
Late evaluation (tertiary evaluation)
We followed up the unexplained patients who could not be
diagnosed in either evaluation. The follow-up period was from
January 1, 2009 to July 31, 2013. The unexplained patients were
divided using a risk stratiﬁcation of unexplained syncope. The risk
stratiﬁcation had three categories, low-risk, low-risk for recur-
rence, and high-risk groups. The high-risk features were deﬁned
according to the ESC guidelines (Table 1) [8]. If a patient without
any high-risk features had only one, or two or more episodes of
syncope, we placed the patient into the low-risk and low-risk for
recurrence groups, respectively. We did not perform any further
syncope tests in the low-risk patients. We advised the appropriate
patients with a suspected arrhythmia nature in the low-risk for
recurrence group and high-risk group to receive an ILR. We
performed conventional tests for the unexplained syncope patients
without indication and agreement of ILR. We compared the
diagnostic rates between the patients with an implanted ILR and
those in the group undergoing conventional tests. We evaluated
the recurrent symptoms after therapy when the unexplained
syncope could be diagnosed in the late evaluation.
Table 2
Patient characteristics.
N 547
Age (years) 60.4  21.5
Male 328 (60.0%)
Hypertension 190 (34.7%)
Diabetes mellitus 60 (11.0%)
Injury 121 (22.1%)
Frequency of syncope (times) 2.1  1.7
Admission 314 (57.4%)
Cardiac disease 261 (47.7%)
Congestive heart failure 19 (3.5%)
Ischemic heart disease 67 (12.2%)
OMI 35 (6.4%)
AP 17 (3.1%)
VSA 13 (2.4%)
Non ischemic heart disease 51 (9.3%)
CM 7 (1.3%)
HCM 13 (2.4%)
HHD 7 (1.3%)
Valvular cardiomyopathy 25 (4.6%)
Arrhythmia 151 (27.6%)
Brugada type ECG 19 (3.5%)
Long QT syndrome 5 (0.9%)
Bifascicular block 10 (1.8%)
SSS 7 (1.3%)
AVB 7 (1.3%)
Atrial ﬁbrillation 94 (17.2%)
AFL 9 (1.6%)
PSVT 8 (1.2%)
VT 13 (2.4%)
Vf 2 (0.3%)
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We implanted the ILR (Medtronic Reveal DX1, Medtronic Inc.,
Minneapolis, MN, USA) subcutaneously in the left pectoral region.
The ILR was able to save three manual activations of 7.5 min and
automatic activations that were programmed as follows: (i) rapid
ventricular tachycardia (RR interval <260 ms in at least 30 of
40 consecutive beats), (ii) ventricular tachycardia (RR interval
261–340 ms in 16 consecutive beats), (iii) pause (>3.0 s), and (iv)
bradycardia (heart rate <30 min1 in 4 consecutive beats).
Statistical analysis
The data were reported as the mean  standard deviation.
Continuous and categorical variables were compared by the means of
a Student’s t-test, Mann–Whitney test, or chi-squared test, as
appropriate. The time from the deﬁnition of the unexplained syncope
to the diagnosis or recurrent symptoms was described by means of
Kaplan–Meier curves and compared with a log-rank test. A p-value
<0.05 was considered statistically signiﬁcant. JMP software version
10.0 was used for the analysis (SAS, Cary, NC, USA).
Results
Patient characteristics and diagnosis
The clinical characteristics are presented in Table 2. The
patients with transient loss of consciousness (T-LOC) accounted for
5.9% (320 patients) of all the patients who were admitted into the
cardiovascular internal medicine department of our hospital. In
the initial and early evaluations, respectively, we could diagnose
208 and 201 patients with syncope, and non-syncope was
diagnosed in 3 and 4 patients, respectively (Fig. 1). Reﬂex syncope
was diagnosed in 29.1% of the cases, OH in 11.7%, and cardiac
syncope in 34.0%. Unexplained syncope was diagnosed in 23.9% of
the cases. Of the cardiac syncope patients, the number of patientsFig. 1. Diagnostic ﬂow chart of the results. Pts, patients; ECG, electrocardin which the syncope was caused by bradycardia arrhythmias
(15.9% of all syncope cases) was greater than that for tachycardia
arrhythmias (9.9%), or structural heart disease (7.6%).
Syncope due to ischemic heart disease was diagnosed in 6.0% of
the total syncope patients. In approximately half of the ischemic
heart disease patients syncope was caused by vasospastic anginaiogram; CT, computed tomography; ILR, implantable loop recorder.
Table 3A
Diagnostic results in the initial and early evaluations.
Syncope Reﬂex syncope Syncope due to OH Cardiac syncope Unexplained syncope
Total 159 (29.1%) 64 (11.7%) 186 (34.0%) 131 (23.9%)
Number Vasovagal syncope 115 (21.0%) Bradycardia 87 (15.9%) Low risk 16 (2.9%)
Situational syncope 35 (6.4%) Tachycardia 54 (9.9%) Low risk, recurrent 45
(8.2%)
Carotid sinus syndrome 9 (1.6%) Ischemic heart disease 33 (6.0%) High risk 70 (12.8%)
Non-ischemic heart disease 9 (1.6%)
Cardiovascular 3 (0.5%)
Age (years) $50.7  22.3 61.0  22.7 ^70.2  15.5 58.1  21.6
OH, orthostatic hypotension.
$ Reﬂex syncope vs. OH, cardiac syncope, unexplained (p < 0.01).
^ Cardiac syncope vs. OH, reﬂex syncope, unexplained (p < 0.01).
Table 3C
Comparison of the syncope patients in the initial and early evaluation.
Deﬁnitive diagnosis Initial
evaluation
Early
evaluation
p-value
Patient characteristics
N 208 201 NS
Age (years) 61.6  21.9 60.6  21.0 NS
Male 120 (57.7%) 117 (57.9%) NS
Female 88 (42.3%) 85 (42.1%) NS
Hypertension 71 (34.1%) 69 (34.2%) NS
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ﬁbrillation with ST elevation after the syncope event.
Further, 22.4% and 84.4% of the non-cardiac syncope and
cardiac syncope patients had cardiac disease, respectively, and
41.0% of the unexplained syncope patients had cardiac disease. The
age of the cardiac syncope patients was signiﬁcantly older than
that of the others (Table 3A). For cardiac syncope, the age of the
patients with bradycardia arrhythmias was the signiﬁcantly
highest cause of the cardiac syncope (bradycardia vs. tachycardia,
and structural heart disease, 76.3  10.9 years vs. 61.6  19.0 years
vs. 67.8  13.2 years, respectively, p < 0.0001).
In the syncope patients with a deﬁnitive diagnosis in the initial
and early evaluations, we analyzed what kind of assessment was
essential to diagnose each syncopal episode. The most essential
test in the initial evaluation was the medical history. The
appropriate rate of the active stand test was only 2.9%. The
diagnostic rate of the prolonged ECG tests (including the 24 hours
Holter ECG and prolonged monitoring) was 18.2%. The diagnostic
rates of EPS and CAG were 23.7% and 31.6%, respectively
(Table 3B).
Comparison between the patients with a deﬁnitive diagnosis in the
initial and early evaluations
The patient characteristics did not signiﬁcantly differ between
the initial and early evaluations. It was possible to diagnose theTable 3B
Diagnostic tests that established the cause of syncope in the initial and early
evaluation.
Diagnostic test Appropriate Diagnostic
yield
Medical history/physical examination 547 (100%) 134 (24.5%)
ECG on consultation (including in
the ambulance)
547 (100%) 79 (14.4%)
Active standing test 16 (2.9%) 8 (50.0%)
Prolonged ECG monitoring 308 (56.3%) 56 (18.2%)
24 hours Holter ECG 286 (52.3%) 31 (10.8%)
Monitoring during admission 201 (36.7%) 17 (8.5%)
External loop recorder 23 (4.2%) 3 (13.0%)
Event monitoring in the cardiac
device
8 (1.5%) 5 (62.5%)
Head-up tilt test (including CS
massage)
232 (42.4%) 91 (39.2%)
CAG (including Ach stress test) 57 (10.4%) 18 (31.6%)
Electrophysiological test 76 (13.9%) 18 (23.7%)
Ultrasound cardiography 300 (54.8%) 9 (3.0%)
Contrast-enhanced CT scan 4 (0.7%) 3 (75.0%)
Treadmill test 53 (9.7%) 2 (3.8%)
ECG, electrocardiogram; CAG, coronary angiography; CT, computed tomogra-
phy; CS, carotid sinus.number of patients with reﬂex syncope in both evaluations, and it
did not differ signiﬁcantly. However, the numbers of situational
syncope and OH patients in the initial evaluation were signiﬁcantly
greater than that in the early evaluation. The number of cardiac
syncope patients in the early evaluation was signiﬁcantly greater
than that in the initial evaluation. The results were strongly
associated with sick sinus syndrome and non-ischemic heart
disease (Table 3C).
Unexplained syncope patients
One hundred thirty-one patients in whom a diagnosis could
not be made in either evaluation were diagnosed with
unexplained syncope. Of those 131 patients, there wereDiabetes mellitus 28 (13.5%) 21 (10.4%) NS
Cardiac disease 108 (51.9%) 99 (49.0%) NS
Congestive heart failure 8 (3.8%) 5 (2.5%) NS
Ischemic heart disease 23 (11.1%) 27 (13.4%) NS
Non ischemic
cardiomyopathy
22 (10.6%) 18 (8.9%) NS
Arrhythmia 56 (26.9%) 67 (33.2%) NS
Diagnosis
Reﬂex syncope 88 (42.3%) 71 (35.3%) NS
Vasovagal syncope 56 (26.9%) 59 (29.3%) NS
Situational syncope 32 (15.4%) 3 (1.5%) <0.0001
Carotid sinus syndrome 0 (0.0%) 9 (4.5%) <0.001
Syncope due to OH 41 (19.7%) 23 (11.4%) <0.05
Cardiovascular syncope 79 (37.9%) 107 (53.2%) <0.01
Bradycardia 37 (17.8%) 50 (24.9%) NS
Sick sinus syndrome 16 (7.7%) 36 (17.9%) <0.001
Atrioventricular block 18 (8.7%) 9 (4.5%) NS
Bradycardia atrial
ﬁbrillation
3 (1.4%) 5 (2.5%) NS
Tachycardia 26 (12.5%) 28 (13.9%) NS
Supraventricular 5 (2.4%) 8 (4.0%) NS
Ventricular 21 (10.1%) 20 (10.0%) NS
Structural heart disease 16 (7.7%) 26 (12.9%) <0.05
Ischemic heart disease 16 (7.7%) 17 (8.5%) NS
Non-ischemic heart
disease
0 (0.0%) 9 (4.5%) <0.01
Vascular disease 0 (0.0%) 3 (1.5%) NS
OH, orthostatic hypotension.
Table 4B
Diagnoses achieved in the late evaluation.
Diagnosis ILR Conventional Total (% of
diagnosed patients)
Bradycardia 8 2 10 (32%)
Supraventricular
tachycardia
2 2 4 (13%)
Ventricular
tachycardia
0 1 1 (3%)
Sinus rhythm
Reﬂex or OH 10 0 10 (32%)
Epilepsy 4 2 6 (19%)
Total 24 7 31 (100%)
ILR, implantable loop recorder; OH, orthostatic hypotension.
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up in the low risk-group at that point. There were 115 patients
in the low-risk recurrent or high-risk groups. Of those
115 patients with unexplained syncope, 81 with a suspected
arrhythmia were diagnosed to have an indication for an ILR
implant. Forty-three (53.1%) of them consented to an ILR
implantation. In particular, in the lone high-risk group, the
proportion of patients was 46.0%. Seventeen patients were
excluded because of incomplete follow-up data (2 patients with
an ILR implantation). We followed up and compared the
diagnostic rates between the 41 patients with an implanted
ILR and 57 that underwent the conventional tests for the late
evaluation during the observation period. The patient char-
acteristics in both groups were not signiﬁcant except for the
admission to a hospital (Table 4A ).
The median follow-up was 18 months from the deﬁnition of
unexplained syncope. There were no death events in the
unexplained syncope patients during the observation period. Of
those 41 unexplained patients with implanted ILRs, syncope was
diagnosed in 24 using the ILR. The estimated diagnostic rates were
47% and 65% at 1 and 2 years, respectively. Ten cardiac syncope
patients, 10 non-cardiac syncope patients, and 4 non-syncope
patients were diagnosed (Table 4B). Of 55 unexplained patients
using conventional tests, 7 were diagnosed. The estimated
diagnostic rates were 14% at 1 and 2 years. Five cardiac syncope
patients, and 2 non-cardiac syncope patients were diagnosed
(Table 4B). Although the symptom-free rate between those
implanted with ILRs and those that underwent conventional tests
was approximately the same, the estimated diagnostic rate in
those implanted with ILRs was signiﬁcantly greater than in those
that underwent conventional tests (Fig. 2A and B). The recurrent
symptom-free rate in the unexplained syncope patients was 50% at
1 year, however the recurrent symptom-free rate in the unex-
plained syncope patients that could be diagnosed and treated was
92.7% at 1 year (Fig. 3). Those 2 patients with recurrent symptoms
after therapy were diagnosed with a recurrence of reﬂex syncope
and OH.
Final diagnosis
The percentages of ﬁnal diagnoses during each evaluation
(initial, early, and late) are shown in Table 5. We were ﬁnally able
to diagnose 81.7% of all T-LOC patients after all evaluations. Of
336 patients that could not be diagnosed in the initial evaluation,
236 patients (70.2%) were able to be diagnosed with syncope in the
early and late evaluations. The numbers of cardiac syncope
patients and non-cardiac syncope patients were 104 (31%) and 122
(36%), respectively (Table 5).Table 4A
Comparison of the characteristics between the use of an ILR and the conventional
group.
Unexplained syncope ILR Conventional p-value
N 41 57 NS
Age (years) 59.5  20.5 60.4  22.6 NS
Male 26 (63.4%) 35 (61.4%) NS
Hypertension 15 (36.6%) 22 (38.6%) NS
Diabetes mellitus 4 (9.8%) 7 (12.3%) NS
Cardiac disease 21 (51.2%) 24 (42.1%) NS
Arrhythmia 10 (24.4%) 17 (29.8%) NS
Frequency of
syncope (times)
2.4  0.2 2.1  0.2 NS
Admission (%) 41 (100%) 26 (45.6%) <0.0001
Injury (%) 19 (46.3%) 16 (28.1%) NS
ILR, implantable loop recorder.Discussion
In this retrospective study of 547 patients, the major ﬁndings
were as follows: (1) Most of our cardiac syncope patients had
cardiac disease, similar to those in Western countries. (2) The
initial evaluation during the ﬁrst medical examination was
important for diagnosing OH and situational syncope. (3) VSA
was an important cause of cardiac syncope and a CAG with an
acetylcholine stress test was used for the diagnosis. (4) The
proportion of unexplained patients with a suspected arrhythmiaFig. 2. (A) Cumulative diagnostic rates between the use of an ILR and conventional
tests. (B) Symptom-free survival curve for the use of an ILR and conventional tests.
Although the symptom-free rate between the group implanted with ILRs and the
conventional test group was approximately the same, the estimated diagnostic rate
in the group implanted with the ILRs was signiﬁcantly greater than that in those
that underwent conventional tests. ILR, implantable loop recorder.
Fig. 3. Symptom-free survival curve after the therapy in patients with diagnosed
unexplained syncope. The proportion of patients free of recurrent symptoms was
92.7% at 1 year after the therapy in patients with diagnosed unexplained syncope.
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was useful for diagnosing unexplained syncope, and the amount of
recurrent symptoms was greatly reduced in the patients with
unexplained syncope that could be diagnosed and treated.
To the best of our knowledge there have been no previous
reports showing the present circumstances of syncope in Japanese
hospitals. We showed the cause of syncope involved in cardiovas-
cular internal medicine. Four hundred-ten syncope patients were
diagnosed in the initial and early evaluations, and the most
frequent cause of syncope was cardiac causes. It is known that
cardiac causes of syncope are more frequently observed in elderly
patients than in young patients and conversely, reﬂex syncope is
more frequent in young patients [9]. Our data for the age
distribution when cardiac syncope presented showed that it was
more frequently due to bradycardia arrhythmias in elderly
patients.
Alboni et al. previously reported that 95% of cardiac syncope
patients had cardiac disease. Thus, they mentioned that the
presence of suspected or certain heart diseases is a strong predictor
of a cardiac cause of syncope [10]. Most of our cardiac syncope
patients had cardiac disease, similarly to their report. However,
41% of the unexplained syncope patients had cardiac disease. We
think that these patients must be carefully followed up.
We were able to diagnose 38.5% of all the T-LOC patients in the
initial evaluation. A previous report [11,12] showed that the initialTable 5
The percentage of ﬁnal diagnoses during each evaluation (initial, early, and late).
Etiology of syncope Initial evaluation Ea
(n = 547) 
Diagnostic rate 211 (38.5%) 
Vasovagal 56 (10.2%) 
Situational 32 (5.85%) 
Carotid sinus syndrome – 
Syncope due to OH 41 (7.5%) 
Non-cardiac syncope 129 (23.6%) 
Sick sinus syndrome 16 (2.9%) 
Atrioventricular block 18 (3.3%) 
Bradycardia atrial ﬁbrillation 3 (0.5%) 
Supraventricular tachycardia 5 (0.9%) 
Ventricular tachycardia 21 (3.8%) 
Ischemic heart disease 16 (2.9%) 
Non-ischemic heart disease – 
Vascular disease – 
Cardiac syncope 79 (14.4%) 
No-syncope 3 (0.5%) 
OH, orthostatic hypotension.evaluation was able to deﬁne the cause of syncope in 23–50% of the
patients. These ﬁndings in the clinical history, physical examina-
tion, or ECG have an important role in diagnosing syncope. In
particular, the initial evaluation was important for diagnosing OH
and situational syncope. The representative test for diagnosing
reﬂex syncope is the HUT, which is not known to be useful for
situational syncope [13,14]. It may not be possible to diagnose OH
by an active standing test according to the conditions at that time
(i.e. improvement in dehydration and withdrawal of the causative
drug). We may not be able to diagnose syncope if we neglect the
initial evaluation.
The diagnostic rate of a prolonged ECG required for a deﬁnitive
diagnosis of syncope was 18.2% for both evaluations. Most of the
patients had cardiac syncope. Croci et al. reported that 16% of
syncope was diagnosed by prolonged ECGs in the syncope unit, and
the proportion diagnosed by an EPS was low [12]. Our study also
showed that the diagnosis of syncope by an invasive EPS was low. A
CAG is not generally included in the diagnostic testing for syncope
in Western countries [12]. The CAG was able to diagnose most
patients with syncope due to VSA without coronary artery stenosis.
The diagnostic method was to infuse acetylcholine into the
coronary artery [15]. Abe et al. reported that VSA is not rare in
Japan and east Asia [16]. VSA is known to induce arrhythmias
[17,18] and failure of the cardiac pump function [19] causing
syncope. In particular, VSA is often the cause of sudden cardiac
death due to ventricular arrhythmias [18]. Two VSA patients were
clinically documented with ventricular ﬁbrillation and ST eleva-
tion after a syncopal event in the present study. Therefore, VSA is
an important illness involved in cardiac syncope in Japan.
We could not diagnose syncope in 23.9% of all the patients until
the initial and early evaluations. There were 115 low-risk recurrent
and high-risk patients. ILRs have been approved for use in Japan
since 2009. The present study started from that same year. The
consent rate for an implantation of an ILR was 53.1%. It is well
known that ILRs are useful devices for diagnosing unexplained
syncope [3–6]. However, we obtained consent from only half of the
appropriate risk patients. To the best of our knowledge this is the
ﬁrst report regarding the consent rate for an ILR in Japan. Farwell
et al. reported the diagnostic efﬁcacy comparison of 201 unex-
plained syncope patients between ILRs and conventional tests in a
prospectively randomized trial [4]. Only 2 unexplained syncope
patients refused the study. Brignole et al. reported that only 6% of
the suspected reﬂex syncope patients refused to have an ILR
implanted for a diagnostic observation [20]. The consent ratesrly evaluation Late evaluation Final diagnosis
(n = 336) (n = 98) (n = 547)
205 (61.0%) 31 (31.6%) 447 (81.7%)
59 (17.6%) 7 (7.1%) 123 (22.5%)
3 (0.9%) 1 (1.0%) 35 (6.4%)
9 (2.7%) – 9 (1.6%)
23 (6.8%) 2 (2.0%) 66 (12.1%)
94 (28.0)% 10 (10.2%) 233 (42.6%)
36 (10.7%) 6 (6.1%) 58 (10.6%)
9 (2.7%) 4 (4.1%) 31 (5.7%)
5 (1.5%) – 8 (1.5%)
8 (2.4%) 4 (4.1%) 17 (3.1%)
20 (6.0%) 1 (1.0%) 42 (7.7%)
17 (5.1%) – 33 (6.0%)
9 (2.7%) – 9 (1.6%)
3 (0.9%) – 3 (0.5%)
107 (31.8%) 15 (15.3%) 201 (36.7%)
4 (1.2%) 6 (6.1%) 13 (2.4%)
T. Onuki et al. / Journal of Cardiology 66 (2015) 395–402 401appear to be lower in the present study. In clinical practice we
must enlighten the unexplained syncope patients to the impor-
tance of diagnosing syncope with ILRs.
ILRs were useful devices for diagnosing syncope in the present
study. The annual cumulative diagnostic rate was calculated to be
43–50% over a maximum follow-up of 2 years in previous Western
reports. The diagnostic rate increased rapidly during the six
months period after the ILR implantation, and was followed by a
linear increase in the subsequent period [4–6]. Their ﬁnding of the
diagnostic rate was consistent with our pattern of the diagnostic
rate. In contrast, a diagnosis could be achieved in only 7 (13%)
unexplained syncope patients that underwent conventional tests.
The curve in the diagnostic rate exhibited a concentrated increase
from 6 months to 12 months after the late evaluation was begun,
and we could not diagnose those patients at all after 12 months
even though recurrent symptoms had developed. It may be
difﬁcult to diagnose unexplained syncope without using an ILR.
However, in the case that unexplained syncope patients could be
diagnosed and treated, the symptom recurrence was greatly
reduced.
There were no death events in the unexplained syncope
patients during the observation period. An ILR is not a treatment
device but a diagnostic device. We should carefully pay attention
when selecting between the conventional method, an ILR, and
cardiac device therapies such as pacemakers and implantable
cardiac deﬁbrillators [21], in order to avoid cardiac death events.
We were ﬁnally able to diagnose 81.7% of all T-LOC patients in
the present study. Of 336 patients that could not be diagnosed
in the initial evaluation, 236 (70.2%) patients could be diagnosed in
the early and late evaluations, and the numbers of cardiac syncope
and non-cardiac syncope patients that could be diagnosed was
about equal. Also, the number of cardiac syncope patients that
were diagnosed in the early evaluation was greater than that in the
initial evaluation. In cases with unexplained syncope in the initial
evaluation, the primary physicians should perform further tests for
more advanced evaluation. However, if the consent rate for ILR in
unexplained syncope patients with appropriate risk in the late
evaluation is high, the diagnostic rate might be higher.
Limitations
Our data were based on a follow-up analysis in the division of
cardiology at a single Japanese university hospital. Reﬂex syncope
is generally the most frequent type of syncope in Western
countries [9,22,23]. The prevalence of the causes of syncope
differs depending on the clinical setting, age of the patients, and
diagnostic deﬁnitions, making a comparison between different
studies difﬁcult [8]. Our data appear to have a patient selection bias
because some of the patients included were referral patients from
neighboring clinics and other medical institutions. Therefore, all
patients consist of a suspected cardiogenic syncope population. In
particular, the incidence of reﬂex syncope and OH appear to be
limited only in the cardiology department. However we have to
diagnose and choose the appropriate treatment for those syncope
patients. It appears worthwhile to determine the facts of the
syncope in Japanese hospitals.
Conclusions
Syncope is induced by various causes. It is important that we
understand the characteristics of each cause of syncope. The ILR
helped to effectively determine the diagnosis for unexplained
syncope. The consent rate for an ILR implantation for appropriate
unexplained syncope was low. The recurrent symptoms in the
patients in whom unexplained syncope could be diagnosed and
treated were greatly reduced. We therefore need to educate thepatients at risk with unexplained syncope about the importance of
making a diagnosis of syncope.
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